94.98

0.64% 0.60

Zimmer Biomet Holdings Inc (ZBH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$94.38

Offen:

$95

24-Stunden-Volumen:

1.94M

Relative Volume:

0.97

Marktkapitalisierung:

$18.12B

Einnahmen:

$8.41B

Nettoeinkommen (Verlust:

$760.80M

KGV:

24.66

EPS:

3.8513

Netto-Cashflow:

$1.05B

1W Leistung:

+6.55%

1M Leistung:

-1.86%

6M Leistung:

+0.21%

1J Leistung:

-4.94%

1-Tages-Spanne:

$94.24

$95.91

1-Wochen-Bereich:

$89.18

$95.91

52-Wochen-Spanne:

$79.12

$106.88

Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile

Firmenname

Zimmer Biomet Holdings Inc

Sektor

Healthcare (1052)

Branche

Medical Devices (143)

Telefon

(574) 267-6131

Adresse

345 EAST MAIN STREET, WARSAW, IN

Mitarbeiter

17,000

Twitter

@zimmerbiomet

Nächster Verdiensttermin

2026-11-04

Neueste SEC-Einreichungen

ZBH's Discussions on Twitter

Compare ZBH vs ABT, MDT, SYK, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ZBH Zimmer Biomet Holdings Inc	94.98	18.12B	8.41B	760.80M	1.05B	3.8513
ABT Abbott Laboratories	104.89	181.50B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	94.75	121.20B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	294.66	113.02B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	44.39	64.33B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.60	49.92B	6.30B	1.07B	1.09B	1.8406

Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-10-07	Eingeleitet	Barclays	Equal Weight
2026-07-28	Eingeleitet	UBS	Buy
2026-07-09	Eingeleitet	BMO Capital Markets	Market Perform
2026-03-23	Herabstufung	BTIG Research	Buy → Neutral
2026-02-20	Eingeleitet	William Blair	Mkt Perform
2026-01-09	Herabstufung	Goldman	Neutral → Sell
2026-01-06	Herabstufung	Raymond James	Outperform → Mkt Perform
2026-01-05	Hochstufung	Evercore ISI	In-line → Outperform
2025-12-16	Herabstufung	Robert W. Baird	Outperform → Neutral
2025-11-06	Herabstufung	JP Morgan	Overweight → Neutral
2025-09-18	Eingeleitet	Rothschild & Co Redburn	Buy
2025-07-15	Hochstufung	Roth Capital	Neutral → Buy
2024-12-17	Hochstufung	JP Morgan	Neutral → Overweight
2024-09-10	Eingeleitet	Wolfe Research	Peer Perform
2024-07-01	Herabstufung	Piper Sandler	Overweight → Neutral
2024-05-30	Eingeleitet	Goldman	Neutral
2024-05-21	Hochstufung	Argus	Hold → Buy
2024-01-04	Herabstufung	Evercore ISI	Outperform → In-line
2023-10-20	Eingeleitet	ROTH MKM	Neutral
2023-08-28	Hochstufung	BTIG Research	Neutral → Buy
2023-05-03	Hochstufung	BofA Securities	Underperform → Neutral
2023-04-11	Hochstufung	Evercore ISI	In-line → Outperform
2023-03-31	Hochstufung	Jefferies	Underperform → Hold
2023-03-29	Eingeleitet	UBS	Sell
2023-03-10	Hochstufung	Piper Sandler	Neutral → Overweight
2023-01-09	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2023-01-05	Hochstufung	Raymond James	Mkt Perform → Outperform
2023-01-03	Herabstufung	Evercore ISI	Outperform → In-line
2022-11-23	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-10-18	Eingeleitet	Barclays	Underweight
2022-10-12	Eingeleitet	Jefferies	Underperform
2022-05-27	Herabstufung	Needham	Buy → Hold
2022-04-13	Herabstufung	Truist	Buy → Hold
2022-04-01	Herabstufung	Citigroup	Buy → Neutral
2022-03-02	Fortgesetzt	BofA Securities	Underperform
2022-03-02	Herabstufung	Loop Capital	Buy → Hold
2022-02-08	Herabstufung	Canaccord Genuity	Buy → Hold
2022-02-08	Bestätigt	Citigroup	Buy
2022-02-08	Bestätigt	Deutsche Bank	Hold
2022-02-08	Bestätigt	JMP Securities	Mkt Outperform
2022-02-08	Bestätigt	JP Morgan	Neutral
2022-02-08	Bestätigt	RBC Capital Mkts	Sector Perform
2022-02-08	Bestätigt	Stifel	Buy
2022-02-08	Bestätigt	Truist	Buy
2022-02-08	Bestätigt	UBS	Neutral
2022-02-08	Bestätigt	Wells Fargo	Underweight
2022-02-02	Herabstufung	UBS	Buy → Neutral
2022-01-19	Herabstufung	Wells Fargo	Equal Weight → Underweight
2022-01-10	Herabstufung	Mizuho	Buy → Neutral
2022-01-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-01-04	Herabstufung	Piper Sandler	Overweight → Neutral
2021-12-10	Eingeleitet	RBC Capital Mkts	Sector Perform
2021-12-09	Herabstufung	Needham	Strong Buy → Buy
2021-12-07	Eingeleitet	Loop Capital	Buy
2021-11-23	Herabstufung	Argus	Buy → Hold
2021-09-14	Fortgesetzt	Raymond James	Mkt Perform
2021-05-25	Eingeleitet	Barclays	Overweight
2021-04-09	Hochstufung	Northland Capital	Market Perform → Outperform
2021-01-04	Hochstufung	Evercore ISI	In-line → Outperform
2020-12-18	Bestätigt	Needham	Strong Buy
2020-10-20	Eingeleitet	Northland Capital	Market Perform
2020-09-11	Eingeleitet	Wolfe Research	Outperform
2020-08-05	Bestätigt	Needham	Strong Buy
2020-04-28	Herabstufung	Guggenheim	Buy → Neutral
2020-04-09	Herabstufung	Evercore ISI	Outperform → In-line
2020-04-07	Bestätigt	Needham	Strong Buy
2020-03-05	Eingeleitet	Citigroup	Buy
2020-02-13	Eingeleitet	Goldman	Buy
2020-01-08	Eingeleitet	SunTrust	Buy
2020-01-07	Hochstufung	Piper Jaffray	Neutral → Overweight
2020-01-07	Hochstufung	Piper Sandler	Neutral → Overweight
2019-12-04	Hochstufung	Raymond James	Outperform → Strong Buy
2019-10-07	Hochstufung	BTIG Research	Neutral → Buy
2019-09-18	Hochstufung	Canaccord Genuity	Hold → Buy
2019-08-12	Hochstufung	Argus	Hold → Buy
2019-07-30	Hochstufung	Barclays	Underweight → Equal Weight
2019-07-29	Hochstufung	Robert W. Baird	Neutral → Outperform
2019-06-11	Hochstufung	Bernstein	Underperform → Mkt Perform
2019-04-24	Hochstufung	Needham	Buy → Strong Buy

Alle ansehen

Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten

Oct 13, 2026

Sept. 3: Zimmer Biomet moving HQ, donating former one to area college - KPCNews

Oct 13, 2026

Zimmer Biomet extends exclusive deal to distrib... - Pluang

Oct 13, 2026

ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT - PR Newswire

Oct 13, 2026

Zimmer Biomet Holdings Inc. R (ZIM.MU) Q2 FY2026 earnings call transcript - Yahoo Finance

Oct 13, 2026

Oct 12, 2026

Surgical Equipment & ConsumablesDiversified Stocks Q2 Results: Benchmarking Zimmer Biomet (NYSE:ZBH) - Yahoo Finance

Oct 12, 2026

Is It Too Late to Buy Zimmer Biomet Holdings Inc (ZBH) After 3.4% Rally? GF Value Says Undervalued - GuruFocus

Oct 12, 2026

Zimmer Biomet gains as investors weigh analyst optimism and prior guidance lift - Quiver Quantitative

Oct 12, 2026

Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 12, 2026

Form 4 Zimmer Biomet Holdings Inc For: 12 October By Investing.com - Investing.com Nigeria

Oct 12, 2026

Should Value Investors Buy Zimmer Biomet (ZBH) Stock? - Zacks Investment Research

Oct 12, 2026

Should Value Investors Buy Zimmer Biomet (ZBH) Stock? - Yahoo Finance

Oct 12, 2026

Leerink Partners Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Cuts Target Price to $97 - Moomoo

Oct 12, 2026

Oct 07, 2026

Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy? - Zacks Investment Research

Oct 07, 2026

Oct 06, 2026

Zimmer Biomet Holdings Inc Share PriceZBH, RNS News, Articles, Quotes, & Charts (NYSE:ZBH) - Proactive financial news

Oct 06, 2026

Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results - Investing News Network

Oct 06, 2026

Are Investors Undervaluing Baxter International (BAX) Right Now? - Zacks Investment Research

Oct 06, 2026

On Nov. 4, Q3 results release will be available at 6:30 a.m. ET before Zimmer Biomet's webcast. - Stock Titan

Oct 06, 2026

Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results - themountaineer.com

Oct 06, 2026

Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results - Yahoo Finance

Oct 06, 2026

Oct 05, 2026

A Look at Zimmer Biomet Holdings Inc (ZBH) After 3.7% Gain -- GF Value $125.41 vs Price $91.57 - GuruFocus

Oct 05, 2026

Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 05, 2026

932 and 480 shares are withheld for taxes as Zimmer Biomet (ZBH) stock awards convert. - Stock Titan

Oct 05, 2026

Options on 7,035 shares expire in 2032 for Zimmer Biomet (ZBH) executive Brian Hatcher. - Stock Titan

Oct 05, 2026

Fully vested options are among Americas president Gary Craig Campbell's Zimmer Biomet (ZBH) holdings. - Stock Titan

Oct 05, 2026

Citi Initiates 90-Day Watch on Zimmer Biomet (ZBH) Ahead of Q3 E - GuruFocus

Oct 05, 2026

Oct 04, 2026

Zimmer Biomet Holdings Inc. (ZIM.SG) Q2 FY2026 earnings call transcript - Yahoo Finance

Oct 04, 2026

Oct 03, 2026

ZBH6004607 Bond Profile: Coupon and Redemption - TradingView

Oct 03, 2026

Oct 02, 2026

A director at Zimmer Biomet (ZBH) acquired 417.363 units payable in cash. - Stock Titan

Oct 02, 2026

A director acquires 306 cash-settled stock units at Zimmer Biomet (ZBH), payable in five annual installments. - Stock Titan

Oct 02, 2026

Director Arthur J. Higgins acquires 306.066 cash-settled units at Zimmer Biomet (ZBH). - Stock Titan

Oct 02, 2026

Director acquires 375.626 cash-settled stock units at Zimmer Biomet (ZBH). - Stock Titan

Oct 02, 2026

A director acquires 174 deferred stock units at Zimmer Biomet (ZBH), payable in shares after service ends. - Stock Titan

Oct 02, 2026

Director Kolli acquires 173.901 deferred stock units at Zimmer Biomet (ZBH). - Stock Titan

Oct 02, 2026

Sep 30, 2026

Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - marketwatch.com

Sep 30, 2026